System amyloidosis with predominant heart disease: own observations.

Authors

  • O. O. Dyadyk P.L.Shupik National Medical Academy of Post-Graduate Education, Ukraine
  • O. S. Baltonkova Bogomolets National Medical University, Kyiv, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2016.3.139-143

Keywords:

amyloidosis, histochemical, immunohistochemical research, λ-, k-light immunoglobulin chains, AA amyloid

Abstract

Background. It is difficult to diagnose amyloidosis at the early stages of disease progress due to long-term symptom-free progression. Several organs are involved in the pathologic process by AL-amyloidosis of predominant number of patients (69%); about 20% have cardiac symptoms and only in 5% of cases the isolated heart disease. Objective: identify peculiarities of heart damage by amyloidosis on the basis of morphologic study of cases with system amyloidosis and justify morphology of amyloid cardiomegaly. Methods. Material for the research was taken during corpse dissection: male - 62 years old and female - 63 years old. In the course of the research autopsy, macro-, microscopic methods, as well as histo- and immunohistochemical methods were used. Results. The amyloidosis was identified after the dissection according to specific outer appearance of organs. Specific histochemical and immunohistochemical reaction for amyloidosis detection were carried out. Taking into account pathomorphological research data and amyloid immunophenotyping, the primary (system) amyloidosis with predomination of λ-, k-light immunoglobulin chains was identified. Conclusions. The heart is the dominant target organ for systemic amyloidosis. Specification of morphological verification including histochemical and immunohistochemical methods is needed to improve diagnostic algorithms.

References

  1. Lutay MI, Holikova IP, Tsyzh AV, Buhayenko VV. [Amyloidosis of heart: difficult diagnosis]. Zdorovya Ukrainy. 2012;(12):34–7. Russian.
  2. Makarevych AE, Artyshevskaya NY, Pochtavtsev AYu, Lavrynovych OA, Babych LA, Zykova YO, Shkundych OE, Palchyk NA. [Amyloidosis of the heart: patomorfopogiya, clinical picture, diagnosis, differential diagnosis, treatment]. Medytsynskyy zhurnal BGMU. 2006;(4):115–25. Russian.
  3. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. American Journal of Hematology. 2005;79:319-28.
  4. Mostbauer GV. [Amyloidosis and heart]. Therapia. 2009;37(5):39-46. Russian.

How to Cite

Dyadyk, O. O., & Baltonkova, O. S. (2016). System amyloidosis with predominant heart disease: own observations. Морфологія / Morphologia / Morfologìâ, 10(3), 139–143. https://doi.org/10.26641/1997-9665.2016.3.139-143

Issue

Section

Статті